NCT04915495 2025-03-21The Use of the LuViva Advanced Cervical Scan to Identify Women at High-Risk for Cervical NeoplasiaGuided TherapeuticsPhase NA Enrolling by invitation400 enrolled
NCT06755515 2025-01-01A Phase Ⅱ/Ⅲ Study of Rulonilimab Plus Chemotherapy± Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical CancerShandong New Time Pharmaceutical Co., LTDPhase 2/3 Enrolling by invitation510 enrolled